An international group of multidisciplinary experts on middle-ear and paediatric infections met
to explore where consensus exists on the management of acute otitis media. After informal …

Background The Finnish Invasive Pneumococcal disease (FinIP) vaccine trial was designed
to assess the effectiveness of a pneumococcal vaccine containing ten serotype-specific …

Most subjects develop antibodies to SARS‐CoV‐2 following infection. In order to estimate
the duration of immunity induced by SARS‐CoV‐2 it is important to understand for how long …

Background The ten-valent pneumococcal conjugate vaccine (PCV10) was introduced into
the Finnish National Vaccination Program (NVP) in September 2010 with a 2+1 schedule (3, …

In acute otitis media (AOM), a means of prediction of the bacterial pathogen based on symptoms
and signs would be valuable in selecting appropriate antimicrobial treatment. Children …

… : Arto Palmu reports a relationship with Sanofi Pasteur Inc that includes: funding grants. Arto
Palmu reports a … Arto Palmu reports a relationship with Pfizer that includes: funding grants. …

Importance Vaccinations are paramount to halt the COVID-19 pandemic, and safety data
are essential to determine the risk-benefit ratio of each COVID-19 vaccine. Objective To …

Background The elderly are highly vulnerable to severe COVID-19. Waning immunity and
emergence of Omicron have caused concerns about reduced effectiveness of COVID-19 …

Background: The novel pneumococcal conjugate vaccine, PncCRM, has been shown to
prevent acute otitis media caused by vaccine serotypes and to reduce otitis surgery. Our aim …

Background Antimicrobial drugs are frequently prescribed to children for respiratory tract
infections such as otitis, tonsillitis, sinusitis, and pneumonia. We assessed the effect of the ten-…